For decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...

Work has begun on something once-unthinkable: creating human DNA from scratch. Artificial DNA has long been an ethical minefield, with fears of a generation of ‘designer babies’ with pick ‘n’ mix ...

Researchers have identified a form of molecular motion that has not previously been observed. When what are known as "guest molecules"—molecules that are accommodated within a host molecule ...

The Linea IVT platform combines DNA IVT templates manufacturing via the LineaDNA platform with a proprietary Linea RNAP to enable mRNA and sa-mRNA manufacturers to produce what Applied DNA ...

The Linea IVT platform combines DNA IVT templates manufacturing via the LineaDNA platform with a proprietary Linea™ RNAP to enable mRNA and sa-mRNA manufacturers to produce what Applied DNA ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the completion of the buildout of its new Good Manufacturing ...

The Linea IVT platform combines DNA IVT templates manufacturing via the LineaDNA platform with a proprietary Linea™ RNAP to enable mRNA and sa-mRNA manufacturers to produce what Applied DNA ...

How can you write data to DNA without changing the base sequence? A new method lets anyone with a kit write data to DNA with just one enzyme.

DNA has tremendous potential as a data storage medium, but the process of synthesizing DNA from scratch is time-consuming. It has to be done one nucleotide at a time in a specific sequence. New ...

Enzymatic DNA synthesis promises to resolve many of the difficulties encountered with chemical DNA synthesis. For example, it promises to sustainably produce more complex templates at either bench ...

A new gene editing technique derived from bacterial “jumping genes” can add, remove, recombine and invert DNA sequences, potentially overcoming some of the limitations of CRISPR. | A new gene ...

CRISPR-Cas9 research shows that human embryos are often unable to repair DNA damage, reinforcing warnings against germline gene editing.